ACTR-11. OVERALL SURVIVAL IN GLIOBLASTOMA PATIENTS TREATED WITH OPTUNE® CORRELATES WITH COMPLIANCE: CONSISTENCY ACROSS STUDIES

Optune® is an FDA-approved portable medical device that delivers continuous treatment with Tumor-Treating Fields (TTFields) to the supratentorial region of the brain and is indicated for the treatment of newly diagnosed glioblastoma multiforme (GBM) in combination with temozolomide and for recurrent...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Potter, Wyatt, Shah, Bimal, Shackelford, Melissa, Davis, Joe, Boatwright, Charles, Certo, Jeanine
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5691920/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.009
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares